Central nervous system relapse of primary cutaneous CD8+ aggressive epidermotropic cytotoxic T-cell lymphoma

Br J Haematol. 2021 Apr;193(1):9. doi: 10.1111/bjh.17267. Epub 2020 Dec 18.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Antimetabolites, Antineoplastic / administration & dosage
  • Antimetabolites, Antineoplastic / therapeutic use
  • Antineoplastic Combined Chemotherapy Protocols
  • Autografts
  • CD8-Positive T-Lymphocytes / metabolism
  • CD8-Positive T-Lymphocytes / pathology
  • Central Nervous System / diagnostic imaging
  • Central Nervous System / pathology*
  • Cranial Nerve Diseases / diagnosis
  • Cranial Nerve Diseases / etiology*
  • Cytarabine / administration & dosage
  • Cytarabine / therapeutic use
  • Humans
  • Lymphoma, T-Cell, Cutaneous / diagnosis*
  • Lymphoma, T-Cell, Cutaneous / drug therapy
  • Magnetic Resonance Imaging / methods
  • Male
  • Methotrexate / administration & dosage
  • Methotrexate / therapeutic use
  • Middle Aged
  • Neoadjuvant Therapy / methods
  • Neoplasm Recurrence, Local / pathology
  • Recurrence
  • Referral and Consultation
  • Remission Induction
  • Skin Neoplasms / pathology*
  • Spinal Puncture / methods
  • Stem Cell Transplantation
  • T-Lymphocytes, Cytotoxic / metabolism
  • T-Lymphocytes, Cytotoxic / pathology
  • Treatment Outcome

Substances

  • Antimetabolites, Antineoplastic
  • Cytarabine
  • Methotrexate